Speakers:

Susan Tsai, Milwaukee, WI Melissa Hogg, Evanston, IL

Faculty:

Conor P. Delaney, Cleveland OH Vassiliki L. Tsikitis, Portland, OR

Sp782
THE HISTORY OF NARPC AND EVOLUTION OF THE STANDARDS
Samantha Hendren, Ann Arbor, MI

Sp783
THE COMMUNITY PERSPECTIVE ON THE ACCREDITATION
Piyush Aggarwal, Walnut Creek, CA

Sp784
THE UNIVERSITY/ACADEMIC CENTER PERSPECTIVE ON THE ACCREDITATION
Daniel Herzig, Portland, OR

Faculty:

Flavio G. Rocha, Portland, OR Sean P. Cleary, Rochester, MN Alexandra Gangi, Los Angeles, CA

Sp773
ENDOSCOPIC MANAGEMENT OF GEP-NETS
Joanna Law, Seattle, WA

Sp774
PANCREATIC NETS: WHEN AND HOW TO RESECT?
Bart Rose, Birmingham, AL

Sp775
NEUROENDOCRINE LIVER METASTASES: RESECTION VS. LIVER-DIRECTED THERAPIES
Jessica Maxwell, Houston, TX

Sp776
EMERGING TARGETED THERAPIES FOR NETS: PRRT AND BEYOND
Thorvardur Halfdanarson, Rochester, MN

Q&A

Faculty:

Puja G. Khaitan, Washington DC

Sp777
THE UTILITY OF PRE-OP AND POST-OP MANOMETRY
Renato Salvador, Padova, Italy

Sp778
LINX, WHERE ARE WE NOW?
Shahin Ayazi, Pittsburgh, PA

Sp779
HYBRID CTIF VS. TOUPET: IS THERE A DIFFERENCE?
Ninh Nguyen, Houston, TX

Sp780
UTILITY OF MESH VS. RELAXING INCISIONS IN PEH REPAIR
Carla Holcomb, Dallas, TX

Sp781
NOVEL REPAIR: POSTERIOR RECTUS SHEATH TECHNIQUE
Yalini Vignaswaran, Chicago, IL

Faculty:

Mukta K. Krane, Seattle, WA Vassiliki L. Tsikitis, Portland, OR

Sp794
"AN ANTIBIOTIC A DAY WILL KEEP THE SURGEON AWAY": MEDICATIONS SHOULD BE THE FIRST LINE OF TREATMENT FOR UNCOMPLICATED ACUTE DIVERTICULITIS
Michelle Cowan, Seattle, WA
&
Kinga Scowron, Chicago, IL

Sp795
HOW MANY DIVERTICULAR ATTACKS BEFORE AN OPERATION? IS A STOMA NECESSARY?
Fadwa Ali, Dallas, TX
&
Katherine Kelley, Kalamazoo, MI

Faculty:

Fernando Herbella, Sao Paulo, Brazil Eduardo Montalvo, Mexico City, Mexico Vikram Kate, Pondecherry, India Haejin In, New Brunswick, NJ

Sp796
CHEMORADIOTHERAPY
Haejin In, Brunswick, NJ

Sp797
CHEMOTHERAPY
Satoru Matsuda, Tokyo, Japan

Sp798
SURGICAL APPROACH TO GASTROESOPHAGEAL JUNCTION CANCER
Mitchell C. Posner, Chicago, IL

Faculty:

Karen Gibbs, Bridgeport, CT Rodolfo Oviedo, Houston, TX Brian Davis, El Paso TX Matthew Hubbard, East Norriton, PA

Sp799
WEIGHT LOSS FROM GASTRIC BYPASS RESOLVES THE REFLUX

Sp800
ANTI-REFLUX SURGERY IN OBESITY SOLVES THE ANATOMICAL ROOT CAUSE OF THE DISEASE
Shaneeta Johnson, Atlanta, GA

Sp801
WHAT'S NEXT- HOW DO WE SURGICALLY TREAT ESOPHAGEAL REFLUX AFTER WEIGHT LOSS SURGERY?
Ian Soriano, San Francisco, CA

Sp802
REVISIONAL BARIATRIC OPTIONS FOR FAILED ANTI-REFLUX SURGERY - WHAT'S THE BEST APPROACH
Christopher DuCoin, Tampa, FL

Sp869
TITLE: “From Operating Room to Board Room: Lessons and Insights”
Peter Pisters, Houston, TX

Authors available at their posters to answer questions 12:30 pm - 1:30 pm; posters on display 9:30 AM - 4 PM.

Speakers:

Timothy Pawlik, Columbus, OH Richard Hodin, Boston, MA

Jump forward to: KELLY AND CARLOS PELLEGRINI SSAT-SAGES JOINT SYMPOSIUM: THE INTERSECTION OF BARIATRIC AND FOREGUT SURGERY

Faculty:

Sergio Bardaro, Cleveland, OH Kevin El-Hayek, Cleveland, OH Yalini Vigneswaran, Chicago, IL Marie King, Albany, NY

Sp879
LAPAROSCOPY
Bruno Zilberstein, Sao Paolo, Brazil

Sp880
ROBOTIC SURGERY
Melissa Hogg, Evanston, IL

Sp881
ENDOSCOPY
Christy Dunst, Portland OR

Moderators:

Thomas Curran, Charleston, SC Sandy H. Fang, Portland, OR Jamie Murphy, London, United Kingdom (8-minute presentation, 6-minute discussion)

723. NEOADJUVANT CHEMORADIOTHERAPY WITH LOCAL EXCISION FOR T2 AND T3 RECTAL CANCERS- MOVING TOWARDS A STANDARD OF CARE
J. H. Marks, H. Saidi, T. Ikner, T. Reif De Paula, D. S. Keller
Lankenau Institute for Medical Research, Wynnewood, PA, United States

724. MUCOSA-ADHERENT BACTERIA REGULATE THE HEALING OF COLONIC ANASTOMOTIC WOUNDS IN COLORECTAL CANCER SURGERY
R. Hajjar^2,1, E. Gonzalez³, G. Fragoso², M. Oliero², A. A. Alaoui^2,1, A. Calvé², H. Vennin Rendos², S. Djediai⁴, T. Cuisiniere², P. Laplante², C. Gerkins², A. S. Ajayi², K. Diop², N. Taleb², S. Thérien², F. Schampaert², H. Alratrout⁵, F. Dagbert⁵, R. Loungnarath⁵, H. Sebajang⁵, F. Schwenter⁵, R. Wassef⁵, R. Ratelle⁵, É. Debroux⁵, J. Cailhier^2,1, B. Routy^2,1, B. Annabi⁴, N. J. Brereton¹, C. S. Richard^5,1, M. M. Santos^2,1
1Surgery, Universite de Montreal, Laval, QC, Canada; ²Centre Hospitalier de l'Universite de Montreal Centre de Recherche, Montreal, QC, Canada; ³McGill University, Montreal, QC, Canada; ⁴Universite du Quebec a Montreal, Montreal, QC, Canada; ⁵Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada

725. RATES OF SURGERY FOR STRICTURING CROHN'S DISEASE IN THE BIOLOGIC ERA
K. M. Fansiwala¹, S. Noorian¹, E. Spartz¹, L. C. DeDecker¹, A. R. Roney¹, J. Turkiewicz², C. Soriano¹, E. Dente¹, A. Sarabia Gonzalez¹, S. Lasitani¹, J. O. Yang¹, J. S. Sauk³, M. Kwaan¹, B. N. Limketkai^3
1University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA, United States; ²UCLA Medical Center Olive View, Sylmar, CA, United States; ³Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, United States

726. IMMUNOREACT 8: IMMUNE MARKERS AS PREDICTORS OF LOCAL TUMOR SPREAD IN PATIENTS UNDERGOING TRANSANAL EXCISION FOR RECTAL CANCER
G. Becherucci¹, C. Ruffolo¹, M. Scarpa², A. Stepanyan¹, I. Maretto¹, O. De Simoni², R. Salmaso¹, G. Spolverato¹, S. Negro¹, I. Angriman¹, A. Kotsafti¹, C. Vignotto¹, F. Scognamiglio¹, M. Zizzo³, F. Marchegiani¹, L. Facci¹, F. Bergamo², S. Brignola¹, G. Businello¹, V. Guzzardo¹, L. Dal Santo¹, C. Ceccon¹, M. Massani⁴, A. Pozza⁴, I. Cataldo⁴, T. Stecca⁴, A. Dei Tos¹, V. Zagonel², P. Pilati², B. Franzato², A. Scapinello², B. Salmaso⁵, G. Pirozzolo⁶, A. Porzionato², M. Agostini², Q. Bao¹, F. Cavallin¹, B. Di Camillo¹, R. Bardini¹, I. Castagliuolo¹, S. Pucciarelli¹, M. Fassan¹, M. Scarpa^1
1Chirurgia Generale ³, Azienda Ospedale Universita Padova, Padova, Veneto, Italy; ²Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Veneto, Italy; ³Arcispedale Santa Maria Nuova di Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy; ⁴Azienda ULSS n ² Marca Trevigiana, Treviso, Veneto, Italy; ⁵Azienda ULSS ⁵ Polesana, Rovigo, Veneto, Italy; ⁶Azienda ULSS ³ Serenissima, Venezia, Veneto, Italy

727. OUTCOMES OF FIRST-LINE PALLIATIVE SYSTEMIC THERAPY ALTERNATED WITH OXALIPLATIN-BASED PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY IN PATIENTS WITH UNRESECTABLE COLORECTAL PERITONEAL METASTASES IN A MULTICENTER, SINGLE-ARM, PHASE II TRIAL
V. C. van de Vlasakker¹, P. Rauwerdink², K. P. Rovers¹, E. Wassenaar², M. J. Deenen¹, J. Nederend¹, C. Huysentruyt¹, R. J. Fijneman³, E. van der Hoeven², G. Raicu², A. Constantinidis⁴, O. Kranenburg⁴, M. Los², G. Creemers¹, J. burger¹, M. Wiezer², S. Nienhuijs¹, R. Lurvink¹, D. Boerma², I. H. de Hingh^1
1Surgery, Catharina Ziekenhuis, Eindhoven, North Brabant, Netherlands; ²Sint Antonius Ziekenhuis, Nieuwegein, Utrecht, Netherlands; ³Antoni van Leeuwenhoek Nederlands Kanker Instituut, Amsterdam, Noord-Holland, Netherlands; ⁴Universitair Medisch Centrum Utrecht, Utrecht, Utrecht, Netherlands

Faculty:

Yun Shin Chun, Houston, TX Emily Winslow, Washington, DC Yoshikuni Kawaguchi, Tokyo, Japan

Sp994
ADVANCED SURGERY FOR CHOLANGIOCARCINOMA
Hauke Lang, Mainz, Germany

Sp995
ADVANCEMENTS IN PARENCHYMAL SPARING LIVER SURGERY
Guido Torzilli, Milano, Italy

Sp996
CONVERSION SURGERY FOR ADVANCED HEPATOCELLULAR CARCINOMA
Junichi Shindoh, Tokyo, Japan

Sp997
MULTIDISCIPLINARY TUMOR BOARD FOR LIVER SURGERY
Catherine Teh, Quezon City, Philippines

Jump back to: KELLY AND CARLOS PELLEGRINI SSAT-SAGES JOINT SYMPOSIUM: HOW WE EDUCATE OUR FELLOWS IN ROBOTIC, LAPAROSCOPY AND OPEN SURGERY

Faculty:

Sergio Bardaro, Cleveland, OH Kevin El-Hayek, Cleveland, OH Yalini Vigneswaran, Chicago, IL KMarie King, Albany, NY

Sp882
HOW I APPROACH HIATAL HERNIA REPAIRS DURING BARIATRIC SURGERY
John Romanelli, Springfield, MA

Sp883
GERD TREATMENT IN PATIENTS WITH BMI 30-35
Aurora Pryor, Stony Brook, NY

Faculty:

Rebecca Anne Snyder, Houston TX Imran Hassan, Cedar Rapids, IA Richard R. Gurski, Porto Alegre, Brazil (abstracts will have 8-minute presentation, 6-minute discussion)

Sp955
ESTABLISHING A SUCCESSFUL SSAT CHAPTER IN INDIA
Vikram Kate, Pondicherry, India

ESTABLISHING A SUCCESSFUL SSAT CHAPTER IN MEXICO
Samuele Kleinfinger, Mexico City, Mexico

Sp956
CHALLENGES IN ESTABLISHING AN INTERNATIONAL SSAT CHAPTER AND LESSON LEARNED
Catherine Teh, Quezon City, Philippines

800. IMPACT OF A NON-THERAPEUTIC LAPAROTOMY IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC CANCER UNDERGOING SURGICAL EXPLORATION TREATED WITH INDUCTION (M)FOLFIRINOX; A TAPS CONSORTIUM STUDY
R. Theijse¹, T. Stoop¹, M. Katz², C. D. Tzeng², A. C. Wei³, A. H. Zureikat⁵, B. Groot Koerkamp⁴, M. G. Besselink^1
1Surgery, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, Netherlands; ²The University of Texas MD Anderson Cancer Center, Houston, TX, United States; ³Memorial Sloan Kettering Cancer Center, New York, NY, United States; ⁴Erasmus MC, Rotterdam, Zuid-Holland, Netherlands; ⁵UPMC, Pittsburgh, PA, United States

801. DISSECTING THE ROLE OF NODAL METASTASES LOCATION IN PANCREATODUODENECTOMY AFTER NEOADJUVANT TREATMENT FOR CANCER: RESULTS FROM A PROSPECTIVE LYMPHADENECTOMY PROTOCOL
L. Maggino, G. Lionetto, A. Bottardi, S. Nobile, F. Casciani, C. Luchini, A. Scarpa, C. Bassi, G. Malleo, R. Salvia
Unit of General and Pancreatic Surgery, Universita degli Studi di Verona Scuola di Medicina e Chirurgia, Verona, Veneto, Italy

Faculty:

Puja G. Khaitan, Washington DC Ulysses Ribeiro, Sao Paulo, Brazil Anne O. Lidor, Madison, WI (8-minute presentation, 6-minute discussion)

807. NISSEN VERSUS TOUPET FUNDOPLICATION QUALITY OF LIFE OUTCOMES COMPARED BY INTRAOPERATIVE ENDOFLIPTM DISTENSIBILITY INDEX RANGE
V. N. VanDruff^1,2, J. R. Amundson¹, S. Joseph^3,2, S. Che², C. J. Zimmermann², S. Ishii², K. Kuchta², H. M. Hedberg², M. Ujiki^2
1General Surgery, University of Chicago Division of the Biological Sciences, Chicago, IL, United States; ²NorthShore University HealthSystem, Evanston, IL, United States; ³Wayne State University, Detroit, MI, United States

808. MANOMETRIC IDENTIKIT OF A FUNCTIONING AND EFFECTIVE FUNDOPLICATION IN THE HIGH-RESOLUTION MANOMETRY ERA
L. Provenzano, M. Santangelo, G. Capovilla, A. Vittori, L. Nicoletti, F. Forattini, G. Nezi, M. Valmasoni, A. Costantini, M. Costantini, R. Salvador
Universita degli Studi di Padova, Padova, Veneto, Italy

809. THE UTILITY OF SYMPTOM ASSOCIATION PROBABILITY (SAP) IN PREDICTING OUTCOME AFTER LAPAROSCOPIC FUNDOPLICATION IN PATIENTS WITH ABNORMAL ESOPHAGEAL ACID EXPOSURE
D. Vaiciunaite¹, S. Eriksson¹, I. Sarici¹, P. Zheng¹, A. H. Zaidi^1,2, B. Jobe¹, S. Ayazi^1,2
1Esophageal Institute, Allegheny Health Network, Pittsburgh, PA, United States; ²Department of Surgery, Drexel University, Philadelphia, PA, United States

810. PROGNOSTIC ROLE OF TUMOR-INFILTRATING LYMPHOCYTES IN TUMOR MICROENVIRONMENT OF GASTRIC CANCER
M. A. Pereira^1,2, M. F. Ramos^1,2, L. Cardili^1,2, R. D. de Moraes^1,2, A. R. Dias^1,2, V. A. Alves^1,2, B. Zilberstein^1,2, E. S. de Mello^1,2, U. Ribeiro^1,2
1Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil; ²Universidade de Sao Paulo Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, São Paulo, Brazil

811. MICROSATELLITE INSTABILITY ON THE PROGNOSIS AND EFFICACY TO CHEMOTHERAPY IN GASTRIC CANCER PATIENTS: A PROPENSITY SCORE-MATCHED STUDY
M. A. Pereira^1,2, M. F. Ramos^1,2, A. R. Dias^1,2, L. Cardili^1,2, V. A. Alves^1,2, B. Zilberstein^1,2, E. S. de Mello^1,2, U. Ribeiro^1,2
1Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil; ²Universidade de Sao Paulo Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, São Paulo, Brazil

Faculty:

Flavio G. Rocha, Portland OR Susan Tsai, Milwaukee, WI Eduardo E. Montalvo-Jave, Mexico City, Mexico (8-minute presentation, 6-minute discussion)

802. TMEM DOORWAYS ARE AN ACTIONABLE TARGET IN PANCREATIC ADENOCARCINOMA
J. C. Mcauliffe¹, J. Petersen², R. Eddy², X. Ye², C. Adkisson¹, D. Entenberg², M. Oktay¹, J. Condeelis², N. Panarelli^1
1Surgery, Montefiore Medical Center, Bronx, NY, United States; ²Albert Einstein College of Medicine, Bronx, NY, United States

803. SURGERY ACCELERATES PANCREATIC LIVER METASTASIS IN AN IMMUNE COMPETENT MOUSE MODEL
J. L. Phipps, I. A. English, J. M. Chu, M. Tsuda, K. A. MacPherson, C. J. Daniel, C. Pelz, J. Brody, B. C. Sheppard, R. Sears, P. J. Worth
Oregon Health & Science University, Portland, OR, United States

804. BIOLOGIC FACTORS ASSOCIATED WITH MAJOR PATHOLOGIC RESPONSE AND SURVIVAL IN PATIENTS AFTER RESECTION OF COLORECTAL LIVER METASTASIS
A. Haddad, H. Maki, R. Ayabe, M. Lendoire, T. E. Newhook, H. S. Tran Cao, Y. Chun, C. D. Tzeng, J. Vauthey
Hepato-Pancreato-Biliary Surgery, The University of Texas MD Anderson Cancer Center Division of Surgery, Houston, TX, United States

805. COLORECTAL CANCER PRIMES LIVER RECRUITMENT OF CCR2+ TUMOR ASSOCIATED MACROPHAGES TO ESTABLISH A PRE-METASTATIC NICHE
T. Nywening, A. Karachristos
University of South Florida, Tampa, FL, United States

806. PROSPECTIVE COHORT STUDY OF COMPLIANCE WITH RISK-STRATIFIED POST-HEPATECTOMY PATHWAYS
A. N. Martin, T. E. Newhook, E. M. Arvide, W. L. Dewhurst, A. M. Jin, H. S. Tran Cao, Y. Chun, J. Vauthey, C. D. Tzeng
Surgical Oncology, The University of Texas MD Anderson Cancer Center Division of Surgery, Houston, TX, United States

TITLE: “Diversity, Equity and Inclusion: Where Are We Now And Where We Need to Go”

Moderators:

Ibironke Oduyebo Rockville, MD Adjoa Anyane-Yeboa Boston, MA

Immediately following the DDW Diversity Symposium, this reception provides a networking opportunity for attendees to gather, discuss relevant issues, and learn more about what each society is doing to promote diversity in GI.

Members Only